| 000 | 01875cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030924.0 | ||
| 008 | 140106s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.05.M.Sc.2013.Mo.O | ||
| 100 | 0 | _aMona Ahmed Abdelatty | |
| 245 | 1 | 0 |
_aOutcome and prognostic factors of ewing's sarcoma : _bExperience of the National Cancer Institute and Children Cancer Hospital in Egypt / _cMona Ahmed Abdelatty ; Supervised Emad Nabil Ebied , Manal Amin Zamzam , Hossam Eldeen Ahmed Elzomor |
| 246 | 1 | 5 |
_aالنتائج وعوامل التكهن بسركومة ايوينج : _bطبقا لتجربة المعهد القومى للأورام ومستشفى سرطان الاطفال |
| 260 |
_aCairo : _bMona Ahmed Abdelatty , _c2013 |
||
| 300 |
_a125 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology | ||
| 520 | _aPurpose : To evaluate prognostic factors survival rate and efficacy of the treatment modalities used for patients with ewing sarcoma family of tumors (ESFT) Conclusions: The presence of metastasis at presentation was the major factor affecting the outcome of patients with ewing sarcoma regarding DFS and OS and its presence is frequently found in patients with other adverse prognostic factors | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aEwing sarcoma | |
| 653 | 4 | _aOverall and disease free survival | |
| 653 | 4 | _aPrognostic factors | |
| 700 | 0 |
_aEmad Nabil Ebied , _eSupervisor |
|
| 700 | 0 |
_aHossam Eldeen Ahmed Elzomor , _eSupervisor |
|
| 700 | 0 |
_aManal Amin Zamzam , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44754 _d44754 |
||